These studies are designed to investigate ways of preventing HIV acquisition.
HPTN 083 – Give PrEP a Shot
|Goal||Assessing the safety and efficacy of cabotegravir, an investigational, long-acting, injectable HIV medication, versus Truvada, the only FDA-approved medication for HIV prevention.|
|Who is eligible to participate||Men who have sex with other men or transgender women (born male) who are older than 18 years of age and in generally good health.|
|Medication||Injectible Cabotegravir & Truvada (also known as PrEP)|